NHS Grampian and Western Isles stroke patients to benefit from rural healthcare innovation

The NHSG Innovation Hub is proud to be collaborating with colleagues at Western Isles Hospital (NHS Western Isles) and Dr Gray's Hospital (NHS Grampian) on an exciting NHS North of Scotland Innovation Hub project commissioned by the Centre for Sustainable Delivery (CfSD). This initiative aims to assess Clopidogrel resistance in stroke patients using an innovative point-of-care testing device – genedrive®.

Running alongside CfSD’s national rollout of lab-based testing, this is the first project of its kind to be coordinated across the NHS North of Scotland Innovation Hub with teams from the two health boards, NHS Grampian and NHS Western Isles, working collaboratively to deliver the initiative.

While all health boards have access to laboratory services, remote and rural communities often face delays due to the need to transport samples over long distances for specialist testing. With this new device, results can be available in as little as 69 minutes, enabling patients to receive the right treatment at the right time.

Over the next 12 months, the project team will monitor performance across both sites and compare results with those from national testing centres. Findings will be evaluated and shared with colleagues across Scotland to inform future service delivery. 🌟

More information can be found here: NHS Grampian and Western Isles stroke patients to benefit from rural healthcare innovation